Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rakovina Therapeutics Inc. has utilized its Deep Docking AI platform to rapidly identify promising drug candidates for cancer treatment, a process that traditionally would take thousands of years. The company plans to validate these candidates and aims to advance a best-in-class drug candidate to human trials.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
